Literature DB >> 23441782

Treatment of multicentric reticulohistiocytosis with adalimumab, minocycline, methotrexate.

Karen C Yeter, Daniel G Arkfeld.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23441782     DOI: 10.1111/j.1756-185X.2012.01762.x

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


× No keyword cloud information.
  4 in total

Review 1.  Multicentric reticulohistiocytosis: a critical review.

Authors:  Carlo Selmi; Adam Greenspan; Arthur Huntley; M Eric Gershwin
Journal:  Curr Rheumatol Rep       Date:  2015-06       Impact factor: 4.592

Review 2.  Multicentric reticulohistiocytosis: case report with response to infliximab and review of treatment options.

Authors:  Cristina C Macía-Villa; Antonio Zea-Mendoza
Journal:  Clin Rheumatol       Date:  2014-04-15       Impact factor: 2.980

Review 3.  Tumor necrosis factor antagonists in the treatment of multicentric reticulohistiocytosis: Current clinical evidence.

Authors:  Hongjun Zhao; Chunmei Wu; Mengyun Wu; Yaou Zhou; Honglin Zhu; Yisha Li; Yunhui You; Hui Luo; Lijing Wang; Xiaoxia Zuo
Journal:  Mol Med Rep       Date:  2016-05-12       Impact factor: 2.952

Review 4.  Multicentric reticulohistiocytosis (MRH): case report with review of literature between 1991 and 2014 with in depth analysis of various treatment regimens and outcomes.

Authors:  Saad Tariq; Steven T Hugenberg; Stefanie A Hirano-Ali; Hassan Tariq
Journal:  Springerplus       Date:  2016-02-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.